Showing results (21-30 of 35) with videos related to
Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|October 19, 2010
5-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}-2(1H)-quinolinones and 3,4-dihydro-2(1H)-quinolinones: dual-acting 5-HT1 receptor antagonists and serotonin reuptake inhibitors. Part 3Steven M Bromidge, Roberto Arban, Barbara Bertani, et al.Farmaco (Societa Chimica Italiana : 1989)|February 28, 2004
3-Methyl pyrrole-2,4-dicarboxylic acid 2-propyl ester 4-(1,2,2-trimethyl-propyl) ester: an exploration of the C-2 position. Part IFabrizio Micheli, Romano Di Fabio, Roberto Benedetti, et al.Bioorganic & Medicinal Chemistry Letters|February 6, 2008
New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systemsFabrizio Micheli, Giorgio Bonanomi, Simone Braggio, et al.Journal of Medicinal Chemistry|September 16, 2010
Exploration of the amine terminus in a novel series of 1,2,4-triazolo-3-yl-azabicyclo[3.1.0]hexanes as selective dopamine D3 receptor antagonistsFabrizio Micheli, Luca Arista, Barbara Bertani, et al.Journal of Medicinal Chemistry|September 29, 2006
A critical assessment of docking programs and scoring functionsGregory L Warren, C Webster Andrews, Anna-Maria Capelli, et al.Journal of Medicinal Chemistry|April 5, 2023
Discovery of a Potent, Selective, and Orally Bioavailable Tool Compound for Probing the Role of Lysophosphatidic Acid Type 2 Receptor Antagonists in Fibrotic DisordersElisabetta Armani, Andrea Rizzi, Nicolò Iotti, et al.Bioorganic & Medicinal Chemistry|December 10, 2002
Synthesis and pharmacological characterisation of 2,4-dicarboxy-pyrroles as selective non-competitive mGluR1 antagonistsFabrizio Micheli, Romano Di Fabio, Paolo Cavanni, et al.ACS Medicinal Chemistry Letters|February 19, 2025
Novel Cyclohexyl Amido Acid Antagonists of Lysophosphatidic Acid Type 1 Receptor for the Treatment of Pulmonary FibrosisMarta Giuliani, Andrea Rizzi, Mafalda Pagano, et al.Journal of Medicinal Chemistry|November 7, 2009
1,2,4-Triazolyl azabicyclo[3.1.0]hexanes: a new series of potent and selective dopamine D(3) receptor antagonistsFabrizio Micheli, Luca Arista, Giorgio Bonanomi, et al.ACS Medicinal Chemistry Letters|November 20, 2024
Design, Synthesis, and Activity of a Novel Series of Pyridazine-Based ALK5 InhibitorsDaniele Pala, Paolo Ronchi, Donatella Rescigno, et al.Pageof 4